Skip Navigation
National Cancer Institute

Bridging Cognitive Science and Clinical Assessment Perspectives


How can we measure cognitive function in clinical populations such as cancer patients? Clinical neuropsychologists have developed robust tools for evaluating neuropsychological function in patients. However, these tools may not be sensitive enough for research purposes, and lack connection to modern cognitive theories. Conversely, modern cognitive science has developed sophisticated theories and sophisticated instruments to test those theories, but these instruments are generally designed for laboratory use and may not be appropriate or convenient for testing patients, particularly in hospital settings.

Specific Aims

  • Stimulate efforts to cross this divide, including the development of new tests based on contemporary cognitive science theories.
  • Research exploring which constructs established neuropsychological tests might be measuring.


Todd S. Horowitz, Ph.D.
Program Director

Back to Key Initiative: Cognitive Changes Related to Cancer and Cancer Treatments